What medications can lead to small fiber neuropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Medications That Can Lead to Small Fiber Neuropathy

Chemotherapeutic agents, fluoroquinolone antibiotics, and statins are the most common medications that can cause small fiber neuropathy, presenting with painful burning sensations, abnormal temperature perception, and autonomic dysfunction. 1, 2

Chemotherapy Agents

Small fiber neuropathy (SFN) from chemotherapy affects nerve terminals involved in temperature and pain perception, leading to characteristic symptoms:

  • Vinca alkaloids (vincristine): Causes painful burning sensations in feet/hands and autonomic dysfunction 1
  • Taxanes (paclitaxel): Associated with painful small fiber damage 1
  • Platinum compounds (oxaliplatin): Causes transient dysesthesia and axonal polyneuropathy 2, 3
  • Bortezomib: Leads to painful small fiber damage with autonomic involvement 1
  • Thalidomide: Causes painful axonal sensorimotor neuropathy that often doesn't improve after drug withdrawal 3

Chemotherapy-induced peripheral neuropathy typically presents with:

  • Burning pain in hands and feet
  • Lancinating (shooting) pain
  • Decreased pain perception in affected areas
  • Abnormal temperature sensation
  • Autonomic symptoms (postural hypotension, bladder disturbances, constipation) 1

Antibiotics

  • Fluoroquinolones (ciprofloxacin, levofloxacin): Associated with sensory or sensorimotor axonal polyneuropathy
    • FDA warnings specifically mention "rare cases of sensory or sensorimotor axonal polyneuropathy affecting small and/or large axons resulting in paresthesias, hypoesthesias, dysesthesias and weakness" 4, 5
    • Symptoms may occur soon after initiation and can be irreversible 5
    • Requires immediate discontinuation if symptoms develop 4, 5

Other Common Medications

  • Statins (HMG-CoA reductase inhibitors): Can cause axonal sensorimotor neuropathy or purely small-fiber neuropathy 3, 6
  • Antiretrovirals (Nucleoside reverse transcriptase inhibitors): Associated with sensory neuropathy through effects on mitochondrial DNA replication 3
  • Cardiovascular drugs: Various agents have been implicated in peripheral neuropathy 6
  • Anticonvulsants and psychotropics: Can cause neuropathic symptoms in some patients 6

Clinical Presentation and Diagnosis

SFN presents with characteristic symptoms:

  • Burning pain in extremities (often worse at night)
  • Lancinating (shooting) pain
  • Paresthesias (tingling, pins and needles)
  • Autonomic dysfunction (sweating abnormalities, orthostatic hypotension)
  • Normal nerve conduction studies (as large fibers are spared) 7, 8

Diagnosis requires:

  1. Clinical symptoms of small fiber involvement
  2. Normal nerve conduction studies (as these test only large fibers)
  3. Abnormal specialized tests:
    • Skin biopsy showing decreased epidermal nerve fiber density
    • Quantitative sensory testing showing abnormal temperature thresholds
    • Autonomic testing (for sweating abnormalities, heart rate variability) 7

Risk Factors for Medication-Induced SFN

Patients are more likely to develop medication-induced neuropathy if they have:

  • Pre-existing neuropathy
  • Diabetes mellitus
  • Genetic predispositions
  • Advanced age 6

Management Considerations

When medication-induced SFN is suspected:

  1. Identify and discontinue the offending medication if possible
  2. Monitor for improvement after discontinuation (some cases may be irreversible)
  3. Consider symptomatic treatment:
    • Duloxetine or gabapentin for neuropathic pain 2, 6
    • Topical treatments for localized symptoms

Important Caveats

  • Early recognition is critical as continued exposure may lead to irreversible damage 1, 5
  • Small fiber neuropathy significantly impacts quality of life and daily functioning 9
  • Standard nerve conduction studies may be normal despite significant symptoms, as these tests primarily assess large fiber function 7
  • Some medications (particularly fluoroquinolones) require immediate discontinuation at the first sign of neuropathy symptoms 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Numbness Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug-Induced Peripheral Neuropathy: A Narrative Review.

Current clinical pharmacology, 2020

Research

Small fiber neuropathy: a common and important clinical disorder.

Journal of the neurological sciences, 2004

Research

Small Fiber Neuropathy: Disease Classification Beyond Pain and Burning.

Journal of central nervous system disease, 2018

Research

Living with small fiber neuropathy: insights from qualitative focus group interviews.

The Journal of international medical research, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.